Amundi Asset Management US’s CUBIST PHARMACEUTICALS INC CBST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q4
Sell
-338,388
Closed -$22.4M 676
2014
Q3
$22.4M Sell
338,388
-20,493
-6% -$1.35M 0.08% 229
2014
Q2
$25.1M Sell
358,881
-9,661
-3% -$657K 0.1% 220
2014
Q1
$27M Sell
368,542
-147,397
-29% -$11M 0.1% 207
2013
Q4
$35.5M Sell
515,939
-170,497
-25% -$11M 0.14% 183
2013
Q3
$43.6M Buy
686,436
+536,236
+357% +$32.4M 0.18% 154
2013
Q2
$7.25M Buy
+150,200
New +$7.38M 0.03% 380

Other funds holding CBST

Amundi Asset Management US's CBST Position: Q4 2014 in Review

Amundi Asset Management US sold out of CUBIST PHARMACEUTICALS INC (CBST) in Q4 2014, closing a stake of 338,388 shares — an estimated $22.4M sold.

Amundi Asset Management US first reported a position in CBST in Q2 2013 and held it in 6 quarters. The position peaked at $43.6M in Q3 2013. 307 funds tracked by Wall St. Rank hold CBST as of Q4 2014.

  • Amundi Asset Management US reported no remaining CUBIST PHARMACEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • Amundi Asset Management US sold 338,388 CUBIST PHARMACEUTICALS INC shares in Q4 2014, an estimated $22.4M.
  • Amundi Asset Management US first reported a position in CUBIST PHARMACEUTICALS INC in Q2 2013 and held it in 6 quarters.
  • Amundi Asset Management US's CUBIST PHARMACEUTICALS INC position peaked at $43.6M in Q3 2013.
  • 307 funds tracked by Wall St. Rank held CUBIST PHARMACEUTICALS INC as of Q4 2014.

Based on Amundi Asset Management US's 13F filing for Q4 2014, filed 9 Feb 2015.